Researchers predicted long-term health consequences and expenses associated with ST-elevation myocardial infarction (STEMI) treatment during the first COVID-19 lockdown.
TLM-101 by Therillume for Neurofibromatoses Type I (Von Recklinghausen’s Disease): Likelihood of Approval
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes